1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Induction Therapy: new trials by email Literature Review of Induction Therapy trials Research Report on Induction Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients. Thymoglobulin [Anti-thymocyte Globulin (rabbit)], Simulect (basliximab) - Cadaveric Donor Renal Transplantation, Acute Renal Allograft Rejection | Phase 2 | Completed | Genzyme, a Sanofi Company | 240 | 2000-05-01 | 2015-03-18 |
Antilymphocyte Serum (1) · Basiliximab (1) · thymoglobulin (1)
France (1) · Germany (1) · Spain (1) · United Kingdom (1) · United States (1)